Angiogenesis-related growth factors and cytokines in the serum of patients with B non-Hodgkin lymphoma; relation to clinical features and response to treatment

International Journal of Laboratory Hematology
Freda H PassamMichael G Alexandrakis

Abstract

Increased angiogenesis has been shown to be a feature of non-Hodgkin lymphomas (NHL). In the current study, the pretreatment levels of circulating molecules related to angiogenesis were determined in 49 B-cell NHL patients and correlated with histological grade, disease stage and prognostic score. In 25 patients, the same molecules were defined after standard treatment. Vascular endothelial growth factor (VEGF), angiogenin, interleukin-2 (IL-2), IL-6, IL-8 and IL-16 were measured. Increased levels of VEGF, IL-6 and IL-8 were found in the whole group of untreated patients in comparison with normal controls (P < 0.05), whereas, IL-2 was higher in the subgroup of indolent NHL. Overall, there was no significant decrease in the levels of these molecules after treatment. However, by stratification into group of responders vs. non-responders pretreatment IL-8 was significantly increased whereas IL-16 was decreased in the subgroup of complete responders. According to the REAL classification IL-2 was higher in the low risk compared with intermediate plus high-risk group. There was no association with disease stage or the International Prognostic Score. Both indolent and aggressive B cell lymphomas have increased production of angiogenic...Continue Reading

References

Oct 1, 1989·The Journal of Clinical Investigation·M BaggioliniS L Kunkel
Nov 18, 1971·The New England Journal of Medicine·J Folkman
Aug 12, 1971·The New England Journal of Medicine·J Folkman
Dec 1, 1982·American Journal of Clinical Oncology·M M OkenP P Carbone
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Jan 12, 1996·The Journal of Biological Chemistry·T CohenB Z Levi
Feb 12, 1998·British Journal of Pharmacology·E SakkoulaM E Maragoudakis
Aug 26, 1998·The Journal of Laboratory and Clinical Medicine·B B MooreR M Strieter
Aug 25, 1999·British Journal of Haematology·F BertoliniG Martinelli
Oct 3, 1999·The Journal of Investigative Dermatology·V BlaschkeC Neumann
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B D ChesonG P Canellos
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H M KantarjianE J Freireich
Jun 17, 2000·Journal of Leukocyte Biology·W W CruikshankD M Center
Nov 25, 2000·British Journal of Haematology·M H Mangi, A C Newland
Apr 11, 2001·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·E Kovacs
Jan 30, 2002·Acta Haematologica·P Salven
Feb 20, 2003·British Journal of Cancer·E PassalidouF Pezzella
Apr 10, 2003·Journal of Cancer Research and Clinical Oncology·Shouji Shimoyama, Michio Kaminishi
Dec 13, 2003·The Hematology Journal : the Official Journal of the European Haematology Association·Michael G AlexandrakisParaskevi Roussou
Feb 3, 2004·American Journal of Hematology·Michael G AlexandrakisElias Castanas
Mar 23, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Felix MorIrun R Cohen
May 22, 2004·Journal of Biomedical Science·Shih-Pei HuangJaw-Town Lin
Dec 1, 2004·Frontiers in Bioscience : a Journal and Virtual Library·Ang YuanPan-Chyr Yang
May 21, 2005·Journal of Applied Physiology·Jessica Y McClintock, Elizabeth M Wagner
Jun 17, 2005·Journal of Physiology and Biochemistry·M el-FarH el-Baz
Aug 24, 2005·British Journal of Haematology·Katerina E PanteliKonstantinos L Bourantas

❮ Previous
Next ❯

Citations

Mar 29, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Shentong FangPetri Salven

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.